Date published: 2025-9-8

021-6093-6350

SCBT Portrait Logo
Seach Input

Lefty 抑制因子

Lefty inhibitors belong to a distinct class of chemical compounds known for their pivotal role in regulating embryonic development and cell differentiation. These inhibitors are closely associated with the transforming growth factor-beta (TGF-β) superfamily of signaling molecules. To understand Lefty inhibitors, it's essential to appreciate their role within the intricate process of embryogenesis. During early development, Lefty inhibitors play a fundamental role in establishing the body plan of an organism. They are known for their function in maintaining symmetry and axis formation, a critical step in the early stages of embryonic development. Lefty inhibitors act as antagonists to certain signaling pathways within the TGF-β superfamily, exerting their influence by interfering with the signaling molecules involved. Specifically, they counteract the activity of Nodal, an important TGF-β member, which plays a key role in specifying the left-right axis in vertebrates. By doing so, Lefty inhibitors help ensure that the developing embryo forms with appropriate bilateral symmetry, preventing developmental abnormalities and ensuring the proper organization of vital organs.

Lefty inhibitors can be broadly classified into two isoforms: Lefty-1 and Lefty-2. Both isoforms exhibit similar mechanisms of action, working as negative regulators by binding to Nodal and inhibiting its signaling. This function is crucial for maintaining the balance of the Nodal pathway, preventing excessive or inappropriate signaling that could lead to developmental defects. Lefty inhibitors are a prime example of the delicate checks and balances that govern embryonic development. Their presence ensures the precise orchestration of signaling pathways, guaranteeing that an organism's body plan and symmetry are established correctly during its early stages of development. Understanding the mechanisms of Lefty inhibitors is not only essential for developmental biology but also holds potential implications for various fields of science and medicine, shedding light on the intricacies of cell signaling and differentiation.

関連項目

Items 1 to 10 of 15 total

展示:

产品名称CAS #产品编号数量价格应用排名

BIBF1120

656247-17-5sc-364433
sc-364433A
5 mg
10 mg
¥2031.00
¥3554.00
2
(0)

Nintedanib 是一种酪氨酸激酶抑制剂,靶向多种受体,包括血管内皮生长因子受体(VEGFR)、成纤维细胞生长因子受体(FGFR)和表皮生长因子受体(PDGFR),抑制血管生成和纤维化途径。

Imatinib mesylate

220127-57-1sc-202180
sc-202180A
25 mg
100 mg
¥496.00
¥1230.00
61
(1)

伊马替尼抑制BCR-ABL酪氨酸激酶,防止慢性髓性白血病(CML)和胃肠道间质瘤(GIST)的异常信号传导。

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
¥824.00
¥2685.00
¥8089.00
¥28453.00
¥241660.00
53
(3)

这种化合物广泛抑制转录物,可能会减少包括 LEFTY 在内的许多基因的表达。

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
¥632.00
¥2933.00
¥4693.00
129
(3)

索拉非尼靶向 RAF 和血管内皮生长因子受体激酶,破坏 MAPK 和血管内皮生长因子通路,而这两种通路在细胞的生长和扩散中发挥作用。

Erlotinib Hydrochloride

183319-69-9sc-202154
sc-202154A
10 mg
25 mg
¥835.00
¥1343.00
33
(1)

厄洛替尼抑制表皮生长因子受体酪氨酸激酶,阻断促进细胞生长和分裂的下游信号通路。

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
¥451.00
¥925.00
¥2888.00
127
(5)

一种可减少 LEFTY 蛋白合成的蛋白质翻译抑制剂。

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
¥1692.00
¥10379.00
5
(0)

舒尼替尼抑制血管内皮生长因子受体(VEGFR)、表皮生长因子受体(PDGFR)和其他激酶,干扰血管生成和肿瘤细胞增殖,主要用于肾细胞癌。

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
¥699.00
¥1264.00
¥2414.00
¥3858.00
74
(2)

吉非替尼(Gefitinib)是表皮生长因子受体酪氨酸激酶抑制剂,通过破坏表皮生长因子受体驱动的信号通路来阻止细胞的生长和分裂。

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
¥530.00
¥1636.00
51
(1)

达沙替尼针对 BCR-ABL 和其他激酶,抑制白血病细胞的增殖,主要用于慢性髓性白血病(CML)。

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
¥395.00
¥1297.00
¥5810.00
26
(1)

鉴于 Wnt 信号和 TGF-β 信号之间的交叉作用,XAV-939 或 ICG-001 等抑制剂可能会间接调节 LEFTY 的表达或活性。